Skip to content
Article Rich – Lifestyle
Author:
Solenic Medical, Inc.
BOYD GAMING TO REPORT SECOND-QUARTER 2026 RESULTS, HOST CONFERENCE CALL AND WEBCAST ON JULY 23
July 1, 2026
Solenic Medical® Receives FDA IDE Approval to Initiate Pivotal Trial of SOLA-2™ for Periprosthetic Joint Infections
June 23, 2026
Solenic Medical Announces Publication in Scientific Reports Demonstrating Enhanced Anti-Biofilm Activity Using Alternating Magnetic Fields
March 5, 2026